Clinical effects of H12 hemodialyzer(AN69 membrane) in hemodialysis patients with uremic pruritus

Clinical effects of H12 hemodialyzer(AN69 membrane) in hemodialysis patients with uremic pruritus - Clinical effects of AN69 membrane in hemodialysis patients with uremic pruritus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002033

Enrollment

Registered

2009-08-31

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

H12 hemodialyzer(AN69)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.hemodialysis patients with pururitus 2.The patient who was provided of the informed consent

Exclusion criteria

Exclusion criteria: 1. Age is under 20 years old 2. Pregnant women, the nursing women or the pregnancy possibility 3. History of sensitivity or side effect to blood purification and/or extracorporeal circulation 4. Patients who participate in the clinical trial of the medicine or medical device or within three months after the end of clinical trial 5. The case that the physician judged to be inappropriate

Design outcomes

Primary

Measure	Time frame
VAS score	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026